Skip to main content
Log in

Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

An altered control of the mechanisms involved in cell proliferation and programmed cell death (apoptosis) might play an important role in parathyroid tumorigenesis. We evaluated by immunohistochemistry the expression of bcl-2 and p53 proteins, as markers of apoptosis control, and MIB-1, as marker of cell proliferation, in a series of normal and neoplastic parathyroid tissues. The specimens were 33 normal parathyroids, 43 parathyroid adenomas and 3 parathyroid carcinomas. Results were scored as positive when more than 1% of cells were stained for MIB-1 and p53, and more than 10% for bcl-2. All normal parathyroids showed numerous bcl-2 positive cells (≥80%), low proliferation rate (MIB-1) and no p53 protein expression. Twenty-four (55%) adenomas were bcl-2 positive; in 16 of these the number of positive cells was high (>50%) and immunoreactivity was diffusely distributed within the adenoma; 8 cases showed a zonal staining pattern, in which groups of stained cells were surrounded by negative cells. Nineteen adenomas (45%) and all carcinomas were bcl-2 negative. A high proliferative rate (MIB-1) was found in all carcinomas and 4 adenomas (9%); all MIB-1 positive adenomas were bcl-2 negative. p53 was negative in all specimens. No significant differences in serum calcium and intact PTH levels nor in tumor size were found between bcl-2 negative and bcl-2-positive and MIB-1-positive and MIB-1-negative adenomas. An inverse, but not statistically significant (p=0.06) correlation was observed between the percentage of bcl-2 positive cells and serum calcium level in parathyroid adenomas. In conclusion, parathyroid adenomas are a heterogeneous group of lesions in which the pattern of bcl-2 and MIB-1 protein expression ranges between that of normal parathyroid (bcl-2 positivity and MIB-1 negativity) and that of parathyroid carcinoma (bcl-2 negativity and MIB-1 positivity). The question of whether the finding of the MIB-1 positive-bcl-2 negative phenotype identifies a subgroup of clinically more aggressive adenomas remains to be established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cattoretti G., Becker M.H.G., Key G., Ouchrow M., Schlüter C., Galle J., Gerdes J. Monoclonal antibodies against recombinant part of the ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in micro-wave processed formalin-fixed paraffin sections. J. Pathol. 168: 357, 1992.

    Article  PubMed  CAS  Google Scholar 

  2. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab V., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133: 1710, 1984.

    PubMed  CAS  Google Scholar 

  3. Hockenbery D.M., Zutter M., Hickey W., Nahm M., Korsmeyer S.J. Bcl2 protein is topographically restricted in tissue characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88: 6961, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Stewart B.W. Mechanism of apoptosis: integration of genetic, biochemical and cellular indicators. J. Natl. Cancer Inst. 86: 1286, 1994.

    Article  PubMed  CAS  Google Scholar 

  5. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jack T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847, 1993.

    Article  PubMed  CAS  Google Scholar 

  6. Hockenbery D., Oltvai Z., Yin X-M., Milliman C., Korsmeyer S.J. bcl-2 functions in an antioxidant pathway of apoptosis. Cell 75: 241, 1993.

    Article  PubMed  CAS  Google Scholar 

  7. Lotem J., Sachs L. Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ. 4: 41, 1993.

    PubMed  CAS  Google Scholar 

  8. Ginsberg D., Mechta F., Yaniv M., Otem M. Wild-type p53 can down modulate the activity of various promoters. Proc. Natl. Acad. Sci Usa 88: 9979, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Abbona G.C., Papotti M., Gasparri G., Bussolati G. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum. Pathol. 26: 135, 1995.

    Article  PubMed  CAS  Google Scholar 

  10. Vargas M.P., Vargas H.I., Kleine D.E., Merino M.J. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod. Pathol. 10: 12, 1997.

    PubMed  CAS  Google Scholar 

  11. Cryns V.L., Rubio M.P., Thor A.D., Louis D.N., Arnold A. p53 abnormalities in human parathyroid carcinomas. J. Clin. Endocrinol. Metab. 78: 1320, 1994.

    PubMed  CAS  Google Scholar 

  12. Cordeil J.L., Falini B., Erber W.N., Ghosh A.K., Abdul-Aziz Z., MacDonald S., Pulford K.A.F., Stein H., Mason D. Immunoenzymatic labelling of monoclonal antibody using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32: 219, 1984.

    Article  Google Scholar 

  13. Hockenbery D.M., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334, 1990.

    Article  PubMed  CAS  Google Scholar 

  14. Lu Q-L., Abel P., Foster C.F., Lalani E-N. bcl-2: role in epithelial differentiation and oncogenesis. Hum. Pathol. 27: 102, 1996.

    Article  PubMed  CAS  Google Scholar 

  15. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Orem M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352, 345–347, 1991.

    Article  PubMed  CAS  Google Scholar 

  16. Hall P.A., Woods A.L. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet. 23: 505, 1990.

    PubMed  CAS  Google Scholar 

  17. Berland Y., Olmer M., Lebreuil G., Grisoli J. Parathyroid carcinoma, adenoma and hyperplasia in a case of chronic renal insufficiency on dialysis. Clin. Nephrol. 18: 154, 1982.

    PubMed  CAS  Google Scholar 

  18. Desch C.E., Arsensis G., May A.G., Amatruda J.M. Parathyroid hyperplasia and carcinoma within one gland. Am. J. Med. 77: 131, 1984.

    Article  PubMed  CAS  Google Scholar 

  19. Arnold A., Staunton C.E., Kim H.G., Gaz R.D., Kronenberg H.M. Monoclonality and abnormal parathyroid hormon genes in parathyroid adenomas. N. Engl. J. Med. 318: 658, 1988.

    Article  PubMed  CAS  Google Scholar 

  20. Schmid K.W., Hittmair A., Ladurner D., Sandbichler P., Gasser R., Tötsch M. Chromogranin A and B parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study. Virchows Arch. A Pathol. Anat. 418: 295, 1991.

    Article  CAS  Google Scholar 

  21. Fain R.P., Kort N.E., Yousry C., James R.M., Litt M. A high resolution CEPH crossover mapping panel and integrated map of chromosome 11. Hum. Mol. Genet. 5: 1631, 1996.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naccarato, A.G., Marcocci, C., Miccoli, P. et al. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues. J Endocrinol Invest 21, 136–141 (1998). https://doi.org/10.1007/BF03347291

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347291

Key-words

Navigation